Corporate News 15-Nov-22
Syngene's biologics facility successfully completes USFDA's pre-approval inspection
Syngene International announced that t the US Food and Drug Administration (FDA) has conducted its pre-approval inspection of the Biologics facility at Bangalore from 07 November 2022 till 15 November 2022. The inspection was completed successfully without 483 observations.
Previous News
Syngene International consolidated net profit rises 20.91% in the March 2023 quarter
( Results - Announcements 27-Apr-23 07:42 )
Syngene Intl gets Rs 16-cr demand order from IT Dept
( Hot Pursuit - 30-Mar-24 13:49 )
Syngene International to convene board meeting
( Corporate News - 29-Jun-24 10:02 )
Syngene International schedules board meeting
( Corporate News - 27-Dec-23 10:57 )
Syngene Intl hit 52-week high after Q4 PAT rises 21% YoY
( Hot Pursuit - 27-Apr-23 10:51 )
Syngene International
( Results - Analysis 24-Jan-23 11:14 )
Syngene International
( Results - Analysis 25-Apr-24 10:22 )
Board of Syngene International recommends Special Dividend
( Corporate News - 27-Apr-23 10:09 )
Board of Syngene International recommends Final Dividend
( Corporate News - 27-Apr-23 10:09 )
Volumes soar at L&T Technology Services Ltd counter
( Hot Pursuit - 15-Jul-22 11:00 )
Volumes jump at Aster DM Healthcare Ltd counter
( Hot Pursuit - 15-Jul-22 14:30 )
Other Stories
Gujarat Natural Resources to convene board meeting
05-Oct-24 17:43
Narmada Macplast Drip Irrigation Sys. to convene board meeting
05-Oct-24 17:43
Grill Splendour Services to conduct board meeting
05-Oct-24 17:43
Consolidated Construction Consortium to hold board meeting
05-Oct-24 17:43
Visagar Polytex to announce Quarterly Result
05-Oct-24 17:42
GNA Axles to convene board meeting
05-Oct-24 17:42
Fidel Softech to conduct board meeting
05-Oct-24 17:42
Rita Finance & Leasing announces board meeting date
05-Oct-24 17:42
Pelatro to conduct EGM
05-Oct-24 17:36
Thinkink Picturez to hold AGM
05-Oct-24 17:35
Back
Top
